Intercept Pharmaceuticals, Inc. (ICPT)
Nov 8, 2023 - ICPT was delisted (reason: acquired by Alfasigma)
19.00
0.00 (0.00%)
Last trade price
Intercept Pharmaceuticals Market Cap
Intercept Pharmaceuticals is not actively traded anymore. When Intercept Pharmaceuticals last traded, it had a market cap or net worth of $794.36 million.
Market Cap
794.36M
Enterprise Value
694.58M
1-Year Change
92.20%
Ranking
Category
Stock Price
$19.00
Market Cap Chart
Since October 11, 2012, Intercept Pharmaceuticals's market cap has increased from $291.60M to $794.36M, an increase of 172.41%. That is a compound annual growth rate of 9.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 7, 2023 | 794.70M | 0.21% |
Nov 6, 2023 | 793.00M | - |
Nov 3, 2023 | 793.00M | - |
Nov 2, 2023 | 793.00M | 0.10% |
Nov 1, 2023 | 792.20M | 0.16% |
Oct 31, 2023 | 790.90M | 0.05% |
Oct 30, 2023 | 790.50M | 0.05% |
Oct 27, 2023 | 790.10M | -0.16% |
Oct 26, 2023 | 791.40M | 0.64% |
Oct 25, 2023 | 786.40M | - |
Oct 24, 2023 | 786.40M | - |
Oct 23, 2023 | 786.40M | 0.81% |
Oct 20, 2023 | 780.10M | 0.05% |
Oct 19, 2023 | 779.70M | 0.27% |
Oct 18, 2023 | 777.60M | -0.05% |
Oct 17, 2023 | 778.00M | -0.22% |
Oct 16, 2023 | 779.70M | 2.54% |
Oct 13, 2023 | 760.40M | -3.97% |
Oct 12, 2023 | 791.80M | 1.18% |
Oct 11, 2023 | 782.60M | 0.54% |
Oct 10, 2023 | 778.40M | - |
Oct 9, 2023 | 778.40M | 0.15% |
Oct 6, 2023 | 777.20M | 0.06% |
Oct 5, 2023 | 776.70M | -0.38% |
Oct 4, 2023 | 779.70M | 0.17% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Definitive Healthcare | 806.15M |
Phreesia | 804.94M |
NewAmsterdam Pharma Company | 800.19M |
Inhibrx | 799.13M |
Kymera Therapeutics | 794.86M |
Brookdale Senior Living | 790.59M |
Akero Therapeutics | 782.88M |
Fulgent Genetics | 780.79M |